Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Get Free Report) saw a large decline in short interest during the month of March. As of March 13th, there was short interest totaling 625,024 shares, a decline of 27.4% from the February 26th total of 861,286 shares. Approximately 11.2% of the shares of the stock are sold short. Based on an average daily volume of 2,223,976 shares, the short-interest ratio is presently 0.3 days.
Baird Medical Investment Trading Down 0.5%
Shares of BDMD opened at $2.02 on Friday. Baird Medical Investment has a one year low of $0.76 and a one year high of $7.26. The company’s fifty day moving average price is $1.72 and its 200 day moving average price is $1.64.
Institutional Trading of Baird Medical Investment
Several hedge funds have recently added to or reduced their stakes in BDMD. Geode Capital Management LLC lifted its position in shares of Baird Medical Investment by 59.7% in the 2nd quarter. Geode Capital Management LLC now owns 25,442 shares of the company’s stock worth $93,000 after acquiring an additional 9,511 shares during the period. Jane Street Group LLC bought a new stake in shares of Baird Medical Investment during the second quarter valued at approximately $142,000. Finally, Citadel Advisors LLC bought a new stake in shares of Baird Medical Investment during the third quarter valued at approximately $99,000. Institutional investors own 19.78% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Stock Report on Baird Medical Investment
Baird Medical Investment Company Profile
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Further Reading
Receive News & Ratings for Baird Medical Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baird Medical Investment and related companies with MarketBeat.com's FREE daily email newsletter.
